Menu Search
Equities

Hospital Corporation of China Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
3869:HKG.HS

Hospital Corporation of China Ltd

Actions
  • Price (HKD)5.14
  • Today's Change0.00 / 0.00%
  • Shares traded11.40k
  • 1 Year change-28.61%
  • Beta0.0004
Data delayed at least 15 minutes, as of Feb 03 2026 07:24 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Hospital Corporation of China Ltd is a company principally engaged in operation and management of hospitals, provision of management services, supply chain services and other ancillary services to certain hospitals and sale of pharmaceutical products. The Company, along with its subsidiaries, operates its businesses through three segments. General hospital services segment is mainly engaged in hospital services including outpatient and inpatient services. Hospital management services segment is mainly involved in the provision of comprehensive management services including operation management services, supply chain services and other ancillary services. Sale of pharmaceutical products segment is mainly involved in sale of pharmaceutical products by the Company’s retail pharmacy. The Company mainly conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)1.66bn
  • Net income in HKD151.38m
  • Incorporated2014
  • Employees1.84k
  • Location
    Hospital Corporation of China Ltd1602, Tower B, Jin Qiu InternationalBuilding, No. 6, Zhichun Road, HaidianBEIJING ChinaCHN
  • Websitehttp://www.hcclhealthcare.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.